Chemotherapy in metastatic breast cancer: A summary of all randomised trials reported 2000-2007.

@article{Wilcken2008ChemotherapyIM,
  title={Chemotherapy in metastatic breast cancer: A summary of all randomised trials reported 2000-2007.},
  author={N. Wilcken and Rachel F Dear},
  journal={European journal of cancer},
  year={2008},
  volume={44 15},
  pages={
          2218-25
        }
}
  • N. Wilcken, Rachel F Dear
  • Published 2008
  • Medicine
  • European journal of cancer
  • AIM To summarise the findings of all randomised trials comparing chemotherapy regimens for metastatic breast cancer that were reported between 2000 and 2007 inclusive. METHODS We searched the specialised register of clinical trials maintained by the secretariat of the Cochrane Breast Cancer Group (CBCG) from 2000 to 2007, and abstracts from the American Society of Clinical Oncology (ASCO) annual scientific meeting (2000-2007). RESULTS Eighty reports of 63 trials were identified as eligible… CONTINUE READING
    57 Citations
    Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome
    • 13
    Overall survival and post-progression survival in advanced breast cancer: a review of recent randomized clinical trials.
    • E. D. Saad, A. Katz, M. Buyse
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2010
    • 132
    Twenty-twenty hindsight: an adjuvant breast cancer trial through the retrospectoscope.
    • 2
    Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience.
    • 78
    Survival of de novo stage IV breast cancer patients over three decades
    • 19

    References

    SHOWING 1-10 OF 61 REFERENCES
    Single agent versus combination chemotherapy for metastatic breast cancer.
    • 190
    Platinum containing regimens for metastatic breast cancer.
    • 55
    Addition of drug/s to a chemotherapy regimen for metastatic breast cancer.
    • 23
    Antitumour antibiotic containing regimens for metastatic breast cancer.
    • 25
    Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.
    • E. Winer, D. Berry, +14 authors L. Norton
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2004
    • 194
    Phase III trial comparing three doses of docetaxel for second-line treatment of advanced breast cancer.
    • 141